Cancer cells disguised as stem cells gain extra resistance

March 27, 2013 by Elin Fugelsnes & Else Lie
There is significant variation between different types of cancer as well as between patients with the same type of cancer. Credit: Shutterstock

Why are certain cancer cells so resistant? The answer may be that they have either retained or acquired attributes normally found in stem cells.

Stem cells are very resilient and have an exceptional capacity to protect themselves. If cancer cells are able to take on such attributes, it is no wonder that it may be difficult to get the better of them.

"It does appear that certain cancer cells have adopted many of the characteristics normally found in stem cells," affirms Stefan Krauss, Research Team Leader at Oslo University Hospital and Managing Director of the Cancer Stem Cell Innovation Center (SFI CAST), a Norwegian Centre for Research-based Innovation.

Malfunction in the signal control mechanisms of cells

Dr Krauss and his colleagues are especially interested in the signals that control the activity of stem cells and how these can be influenced. One of these signals is Wnt/β–catenin, found in many types of stem cells.

"Both we and other researchers have discovered that this signal is present in unusually large amounts in many cancer cells, particularly cancer cells with a greater resemblance to stem cells than normal cancer cells," Dr Krauss explains.

Wnt/β-catenin is part of a signalling system comprising many that ensure that the cell contains the proper amount of the signal. These mechanisms fail occasionally, which may result in unusually aggressive and .

Testing a molecule that could change the attributes of cancer cells

Dr Krauss and his colleagues see opportunity in this tremendous challenge. If the Wnt/β-catenin signal in cancer cells can be controlled it may be possible to alter the properties of cancer cells.

The efforts of the Oslo-based researchers over the past five years have made them world leaders in their field. The researchers have located and further developed a molecule that specifically reduces the amount of Wnt/β–catenin in certain cancer cells, and are now testing the molecule in animal models (mice).

"We have seen that the molecule has a significant effect on certain types of cancer, making the cancer cells look less like stem cells and more like mature, differentiated cells. It appears, then, that the cells will also be more receptive to traditional treatment," explains Stefan Krauss.

He emphasises, however, that it is important to maintain realistic expectations.

"Cancer cells vary greatly. In addition, there is significant variation between different types of cancer as well as between patients with the same type of cancer," Dr Krauss points out.

Detrimental to stem cells?

Another obstacle is that the molecule discovered by Dr Krauss and his group can also affect stem cells. What this means and whether it is a problem remains to be determined.

"This is a new treatment principle, and we have to take one step at a time in order to see what occurs in cancer cells and in stem cells. Any side effects in will have to be weighed against the positive effects on ," concludes Professor Krauss.

The Norwegian researchers are currently in discussion with two major international pharmaceutical companies concerning the further development of for testing on human subjects.

Explore further: Cancer stem cell vaccine in development shows antitumor effect

Related Stories

Cancer stem cell vaccine in development shows antitumor effect

April 2, 2012
Scientists may have discovered a new paradigm for immunotherapy against cancer by priming antibodies and T cells with cancer stem cells, according to a study published in Cancer Research, a journal of the American Association ...

Regulation of telomerase in stem cells and cancer cells

June 27, 2012
Scientists at the Max Planck Institute of Immunobiology and Epigenetics in Freiburg have gained important insights for stem cell research which are also applicable to human tumours and could lead to the development of new ...

Cancer stem cells recruit normal stem cells to fuel ovarian cancer

July 18, 2011
Researchers at the University of Michigan Comprehensive Cancer Center have found that a type of normal stem cell fuels ovarian cancer by encouraging cancer stem cells to grow.

Recommended for you

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

November 20, 2017
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James) identifies a substance released by pancreatic cancer cells that protects ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.